Related Experiment Video
Updated: Aug 5, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Efficacy of probiotics in preventing atopic dermatitis in infants: A systematic review and meta-analysis
1Department of Pediatrics, Beijing Friendship Hospital, Capital Medical University, China.
Insights
Probiotic supplementation in infants does not prevent atopic dermatitis. Current evidence does not support routine use for prevention, as benefits seen in other studies involved maternal and infant regimens.
Area of Science:
- Pediatric Allergy and Immunology
- Microbiome Research
- Preventive Medicine
Background:
- Probiotic modulation of infant gut microbiota is explored for atopic dermatitis prevention.
- Existing evidence on probiotics for preventing atopic dermatitis in infants is inconsistent.
Purpose of the Study:
- To systematically review and meta-analyze randomized controlled trials on probiotic supplementation in infants (0-36 months) for atopic dermatitis prevention.
- To assess the clinical relevance and efficacy of infant-only probiotic use.
Main Methods:
- Systematic search of PubMed, Web of Science, EMBASE, and Cochrane Library up to January 2026.
- Inclusion of randomized controlled trials in infants aged 0-36 months comparing probiotics to placebo or no intervention.
- Risk of bias assessment using Cochrane risk of bias 2 tool and random-effects meta-analysis.
Main Results:
- Eighteen randomized controlled trials with 10,195 participants were analyzed.
- No significant protective effect of probiotics against atopic dermatitis was found (Risk Ratio = 0.94; 95% CI: 0.72-1.25).
- Substantial heterogeneity (I² = 72.8%) was observed; sensitivity analyses confirmed robustness, and no publication bias was detected.
Conclusions:
- Current evidence does not support routine probiotic supplementation solely during infancy for atopic dermatitis prevention.
- Positive effects in prior meta-analyses may stem from perinatal (maternal-plus-infant) regimens, not infant-only supplementation.
- Infant-only probiotic supplementation has not demonstrated consistent preventive benefits for atopic dermatitis.
Abstract:
ObjectiveAlthough probiotic modulation of the gut microbiota in early life has been proposed to prevent atopic dermatitis, supportive evidence remains inconsistent. This systematic review and meta-analysis aimed to determine whether probiotic supplementation initiated during infancy (0-36 months) reduces the risk of atopic dermatitis and provide clinically relevant insights.MethodsThe PubMed, Web of Science, EMBASE, and Cochrane Library databases were searched up to 8 January 2026 for randomized controlled trials comparing probiotics with placebo or no intervention for the prevention of atopic dermatitis. To be eligible, studies needed to have enrolled infants aged 0-36 months. Risk of bias was assessed using the Cochrane risk of bias 2 tool, and a random-effects meta-analysis was performed.ResultsEighteen randomized controlled trials (10,195 participants) were included. Pooled analysis showed that there was no significant protective effect of probiotics against atopic dermatitis (risk ratio = 0.94; 95% confidence interval: 0.72-1.25; p = 0.66), with substantial heterogeneity (I2 = 72.8%). Sensitivity analyses confirmed robustness, and no publication bias was detected (Egger's test, p = 0.15). Two studies featured a high risk of bias, predominantly due to missing outcome data.ConclusionsCurrent evidence does not support routine probiotic supplementation initiated only during infancy for the prevention of atopic dermatitis. Positive preventive effects reported in previous meta-analyses are largely driven by perinatal (maternal-plus-infant) regimens, whereas infant-only supplementation has failed to demonstrate consistent benefit.INPLASY registration number: INPLASY202650128.
Related Concept Videos
Microbiota Modulation by Antibiotics
Development of Human Microbiota
Acne Infection
Development of the Oral Microbiota
